Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Capital Reinvestment Ratio
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Capital Reinvestment Ratio of 0.09x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥178.57 Million) in capital expenditures (CN¥15.27 Million). See free cash flow generation of Hubei Jumpcan Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hubei Jumpcan Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Hubei Jumpcan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see Hubei Jumpcan Pharmaceutical Co Ltd (600566) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥1.20 Billion | CN¥95.86 Million | ▼ -0.1% |
| 2024 | 0.08x | CN¥2.18 Billion | CN¥174.34 Million | ▼ -8.0% |
| 2023 | 0.09x | CN¥3.46 Billion | CN¥301.64 Million | ▼ -6.3% |
| 2022 | 0.09x | CN¥2.62 Billion | CN¥243.66 Million | ▼ -29.1% |
| 2021 | 0.13x | CN¥1.89 Billion | CN¥248.32 Million | ▼ -45.6% |
| 2020 | 0.24x | CN¥1.78 Billion | CN¥429.63 Million | ▼ -5.2% |
| 2019 | 0.25x | CN¥2.15 Billion | CN¥546.44 Million | ▼ -34.9% |
| 2018 | 0.39x | CN¥1.71 Billion | CN¥668.06 Million | ▼ -37.7% |
| 2017 | 0.63x | CN¥1.19 Billion | CN¥746.25 Million | ▲ +77.2% |
| 2016 | 0.35x | CN¥913.10 Million | CN¥323.49 Million | ▼ -42.2% |
| 2015 | 0.61x | CN¥645.48 Million | CN¥395.98 Million | ▲ +25.4% |
| 2014 | 0.49x | CN¥616.11 Million | CN¥301.51 Million | ▼ -48.0% |
| 2013 | 0.94x | CN¥287.16 Million | CN¥270.10 Million | ▼ -43.1% |
| 2012 | 1.65x | CN¥27.01 Million | CN¥44.67 Million | ▼ -98.9% |
| 2011 | 147.69x | CN¥411.24K | CN¥60.74 Million | ▲ +9770.9% |
| 2010 | 1.50x | CN¥51.13 Million | CN¥76.50 Million | ▲ +2.4% |
| 2009 | 1.46x | CN¥4.92 Million | CN¥7.19 Million | ▲ +304.4% |
| 2008 | 0.36x | CN¥23.05 Million | CN¥8.33 Million | ▲ +69.4% |
| 2007 | 0.21x | CN¥36.72 Million | CN¥7.83 Million | ▼ -98.3% |
| 2006 | 12.22x | CN¥4.24 Million | CN¥51.83 Million | ▲ +1194.8% |
| 2005 | 0.94x | CN¥63.38 Million | CN¥59.80 Million | ▼ -94.7% |
| 2003 | 17.83x | CN¥2.24 Million | CN¥39.99 Million | ▲ +235.0% |
| 2002 | 5.32x | CN¥22.00 Million | CN¥117.09 Million | ▼ -55.1% |
| 2001 | 11.86x | CN¥7.43 Million | CN¥88.07 Million | ▲ +1349.6% |
| 2000 | 0.82x | CN¥23.73 Million | CN¥19.41 Million | — |